Li Bai

1.9k citations
74 papers · 1.1k indexed · h-index 19
Topics
Liver Disease Diagnosis and Treatment (15 papers)Hepatocellular Carcinoma Treatment and Prognosis (12 papers)Pancreatic and Hepatic Oncology Research (8 papers)

In The Last Decade

Li Bai

71 papers receiving 1.1k citations

Peers

Li Bai
Comparison fields: 5 of 104
  • Epidemiology 359
  • Molecular Biology 288
  • Oncology 281
  • Hepatology 237
  • Surgery 181
Replace Xiongxiong Pan with:
Xiongxiong Pan China
Anna Moles Spain
Chengwei Chen China
Feixiang Wu China
Haofeng Ji United States
Jianhua Rao China
Betty Zhang Canada
Shao-wei Li China
Shi Yue China
Li Bai relative to Xiongxiong Pan China Xiongxiong Pan's profile →
Citations per field
00.5×2.8×
Xiongxiong Pan · 1×
Citations per year

Countries citing papers authored by Li Bai

Since Specialization
Citations

This map shows the geographic impact of Li Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Bai more than expected).

Fields of papers citing papers by Li Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Bai. The network helps show where Li Bai may publish in the future.

Co-authorship network of co-authors of Li Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Li Bai. A scholar is included among the top collaborators of Li Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Bai. Li Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 0
4 2
5 2
6 2
7 11
8 4
9 30
10 11
11 8
12 2
13 4
14 35
15 10
16 9
17
Association between CTLA-4 rs231775 polymorphism and risk of colorectal cancer: a meta analysis.
8
18
[Clinical efficacy observation of cetuximab combined with chemotherapy in the treatment of metastatic colorectal carcinoma].
1
19 6
20 1

About Li Bai

Li Bai is a scholar working on Hepatology, Computational Mathematics and Oncology, having authored 74 papers that have together received 1.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (15 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers) and Pancreatic and Hepatic Oncology Research (8 papers). The work is most often cited by research in Hepatology (237 citations), Computational Mathematics (7 citations) and Epidemiology (359 citations). Li Bai has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Sujun Zheng, Zhongping Duan, Zhiyuan Mao, Xiaohui Zhang, Shunchang Jiao, Guifang Wang, Chunxue Bai, Chunling Dong, Cha‐Xiang Guan and Kui Xiao. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and NeuroImage.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026